These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31449665)
1. Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Alegría-Landa V; Jo-Velasco M; Santonja C; Eraña I; Vergara-Sanchez A; Kutzner H; Requena L J Cutan Pathol; 2020 Jan; 47(1):12-16. PubMed ID: 31449665 [TBL] [Abstract][Full Text] [Related]
2. Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry. Friedman BJ; Sahu J; Solomides CC; Connolly DM; Lee JB J Cutan Pathol; 2018 Mar; 45(3):212-216. PubMed ID: 29206289 [TBL] [Abstract][Full Text] [Related]
3. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature]. Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666 [TBL] [Abstract][Full Text] [Related]
4. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies. Konstantinova AM; Kyrpychova L; Nemcova J; Sedivcova M; Bisceglia M; Kutzner H; Zamecnik M; Sehnalkova E; Pavlovsky M; Zateckova K; Shvernik S; Spurkova Z; Michal M; Kerl K; Kazakov DV Am J Dermatopathol; 2019 Apr; 41(4):281-285. PubMed ID: 30398985 [TBL] [Abstract][Full Text] [Related]
5. Contiguous squamous proliferations in syringocystadenoma papilliferum: A retrospective study of 14 cases. Aggarwal D; Chatterjee D; Keshavamurthy V; Chhikara K; Saikia UN; Radotra BD; De D; Singh MP Indian J Dermatol Venereol Leprol; 2023; 89(2):266-273. PubMed ID: 34623039 [TBL] [Abstract][Full Text] [Related]
6. Syringocystadenoma Papilliferum in Coexistence With Verrucous Carcinoma on the Face. Park JH; Kim BY; Shin JJ; Kim IH Dermatol Surg; 2018 Aug; 44(8):1144-1146. PubMed ID: 29112527 [No Abstract] [Full Text] [Related]
7. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components. Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472 [No Abstract] [Full Text] [Related]
8. Verrucous carcinoma arising within syringocystadenoma papilliferum. Monticciolo NL; Schmidt JD; Morgan MB Ann Clin Lab Sci; 2002; 32(4):434-7. PubMed ID: 12458900 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis. Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022 [No Abstract] [Full Text] [Related]
10. Syringocystadenoma papilliferum on the mons pubis. Suzuki S; Al-Hajjaj S; Lee M; Bhawan J Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906013 [TBL] [Abstract][Full Text] [Related]
11. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor. Hsu PJ; Liu CH; Huang CJ J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782 [TBL] [Abstract][Full Text] [Related]
12. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma. Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517 [TBL] [Abstract][Full Text] [Related]
13. Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum. Levinsohn JL; Sugarman JL; Bilguvar K; McNiff JM; Choate KA; The Yale Center For Mendelian Genomics J Invest Dermatol; 2015 Oct; 135(10):2536-2538. PubMed ID: 25950823 [No Abstract] [Full Text] [Related]
14. Syringocystadenoma papilliferum arising in a naevus sebaceous. Faheem NAA; Kwan Z; Yong ASW; Ch'ng CC; Tan KK; Naicker M; Tan LL Malays J Pathol; 2019 Apr; 41(1):47-49. PubMed ID: 31025637 [TBL] [Abstract][Full Text] [Related]
15. Syringocystadenoma Papilliferum of the External Auditory Canal. Bruschini L; Ciabotti A; De Vito A; Forli F; Cambi C; Ciancia EM; Berrettini S Am J Case Rep; 2017 May; 18():520-524. PubMed ID: 28490727 [TBL] [Abstract][Full Text] [Related]
16. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum. Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942 [TBL] [Abstract][Full Text] [Related]